Our results could not support our hypothesis that molecular alterations were disproportionately distributed between different age groups of CRC patients, but they indicated that sporadic CRC had similar molecular alterations between different age groups of CRC patients except for PTEN and HRAS mutation. This evidence concerns the gene PTEN and colorectal carcinoma.